Published in Eukaryot Cell on December 13, 2013
Extracellular vesicle-mediated export of fungal RNA. Sci Rep (2015) 0.94
Exosomes and Other Extracellular Vesicles: The New Communicators in Parasite Infections. Trends Parasitol (2015) 0.93
Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids. MBio (2015) 0.85
Virulence-Associated Enzymes of Cryptococcus neoformans. Eukaryot Cell (2015) 0.84
Fungal Melanin: What do We Know About Structure? Front Microbiol (2015) 0.81
Challenges posed by extracellular vesicles from eukaryotic microbes. Curr Opin Microbiol (2014) 0.81
The vacuolar-sorting protein Snf7 is required for export of virulence determinants in members of the Cryptococcus neoformans complex. Sci Rep (2014) 0.79
A P4 - ATPase subunit of the Cdc50 family plays a role in iron acquisition and virulence in Cryptococcus neoformans. Cell Microbiol (2017) 0.75
The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans. Front Microbiol (2017) 0.75
Tramesan, a novel polysaccharide from Trametes versicolor. Structural characterization and biological effects. PLoS One (2017) 0.75
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS (2009) 16.37
A colorimetric method for the determination of sugars. Nature (1951) 8.76
Glycosyl-phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane. Science (1988) 3.41
Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol (2001) 3.11
Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods (1992) 2.97
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun (1996) 2.67
Drs2p-related P-type ATPases Dnf1p and Dnf2p are required for phospholipid translocation across the yeast plasma membrane and serve a role in endocytosis. Mol Biol Cell (2003) 2.65
Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell (2006) 2.55
Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell (2007) 2.42
Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect Immun (1998) 2.10
Role for Drs2p, a P-type ATPase and potential aminophospholipid translocase, in yeast late Golgi function. J Cell Biol (1999) 2.07
The P4-ATPase TAT-5 inhibits the budding of extracellular vesicles in C. elegans embryos. Curr Biol (2011) 2.06
An essential subfamily of Drs2p-related P-type ATPases is required for protein trafficking between Golgi complex and endosomal/vacuolar system. Mol Biol Cell (2002) 2.04
The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol (2009) 1.97
A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol Biol Cell (2006) 1.88
Drs2p-coupled aminophospholipid translocase activity in yeast Golgi membranes and relationship to in vivo function. Proc Natl Acad Sci U S A (2004) 1.85
Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol (1999) 1.79
Drs2p-dependent formation of exocytic clathrin-coated vesicles in vivo. Curr Biol (2002) 1.75
Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes. Cell Microbiol (2008) 1.73
Lipid flippases and their biological functions. Cell Mol Life Sci (2006) 1.68
Inositol phosphorylceramide synthase is located in the Golgi apparatus of Saccharomyces cerevisiae. Mol Biol Cell (2000) 1.67
Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell (2004) 1.64
Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot Cell (2007) 1.63
Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med (1997) 1.60
Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot Cell (2005) 1.58
Pathways of unconventional protein secretion. Curr Opin Biotechnol (2010) 1.55
Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect Immun (1996) 1.53
Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Mol Microbiol (2008) 1.46
Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot Cell (2007) 1.45
Unconventional protein secretion. Trends Plant Sci (2012) 1.44
The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol Microbiol (2006) 1.37
The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays. Clin Diagn Lab Immunol (1998) 1.37
Linking phospholipid flippases to vesicle-mediated protein transport. Biochim Biophys Acta (2009) 1.34
Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res (2012) 1.31
Vesicle-associated melanization in Cryptococcus neoformans. Microbiology (2009) 1.31
A fluorescent derivative of ceramide: physical properties and use in studying the Golgi apparatus of animal cells. Methods Cell Biol (1989) 1.29
The Arabidopsis P4-ATPase ALA3 localizes to the golgi and requires a beta-subunit to function in lipid translocation and secretory vesicle formation. Plant Cell (2008) 1.23
Structural organization of the Golgi apparatus. Curr Opin Cell Biol (2010) 1.22
Estimating the relative contributions of virulence factors for pathogenic microbes. Infect Immun (2006) 1.21
Vesicle and vesicle-free extracellular proteome of Paracoccidioides brasiliensis: comparative analysis with other pathogenic fungi. J Proteome Res (2012) 1.20
Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proc Natl Acad Sci U S A (2009) 1.19
Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Infect Immun (2009) 1.18
The pathogenic fungus Paracoccidioides brasiliensis exports extracellular vesicles containing highly immunogenic α-Galactosyl epitopes. Eukaryot Cell (2011) 1.14
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect Immun (1997) 1.10
Antibody interactions with the capsule of Cryptococcus neoformans. Infect Immun (2000) 1.10
Derivatization of carbohydrates for GC and GC-MS analyses. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 1.09
Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan. Fungal Genet Biol (2009) 1.07
Functions of phospholipid flippases. J Biochem (2010) 1.03
The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles. J Proteomics (2013) 1.00
Glycosyltransferases and their products: cryptococcal variations on fungal themes. FEMS Yeast Res (2006) 1.00
SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans. Mol Microbiol (2011) 0.99
Cryptococcus neoformans requires the ESCRT protein Vps23 for iron acquisition from heme, for capsule formation, and for virulence. Infect Immun (2012) 0.98
Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene. Infect Immun (1997) 0.97
Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence. Mol Microbiol (2011) 0.95
Vesicular transport systems in fungi. Future Microbiol (2011) 0.95
Vesicular mechanisms of traffic of fungal molecules to the extracellular space. Curr Opin Microbiol (2013) 0.94
A putative P-type ATPase, Apt1, is involved in stress tolerance and virulence in Cryptococcus neoformans. Eukaryot Cell (2009) 0.93
Toll-like receptor 4 (TLR4)-dependent proinflammatory and immunomodulatory properties of the glycoinositolphospholipid (GIPL) from Trypanosoma cruzi. J Leukoc Biol (2007) 0.92
The still obscure attributes of cryptococcal glucuronoxylomannan. Med Mycol (2009) 0.92
The vacuolar Ca²(+) exchanger Vcx1 is involved in calcineurin-dependent Ca²(+) tolerance and virulence in Cryptococcus neoformans. Eukaryot Cell (2010) 0.91
Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties. Eukaryot Cell (2012) 0.86
Unravelling secretion in Cryptococcus neoformans: more than one way to skin a cat. Mycopathologia (2011) 0.85
Phosphodiesterases in neurodegenerative disorders. IUBMB Life (2012) 0.84
Regulation of membrane traffic in the secretory pathway. Harvey Lect (1996) 0.83
Where do they come from and where do they go: candidates for regulating extracellular vesicle formation in fungi. Int J Mol Sci (2013) 0.83
Polypeptide translocation machinery of the yeast endoplasmic reticulum. Experientia (1996) 0.82
A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan. Fungal Genet Biol (2012) 0.81
The calcium transporter Pmc1 provides Ca2+ tolerance and influences the progression of murine cryptococcal infection. FEBS J (2013) 0.78
Extracellular vesicles: budding regulated by a phosphatidylethanolamine translocase. Curr Biol (2011) 0.77
Homocysteine induces phosphatidylserine exposure in cardiomyocytes through inhibition of Rho kinase and flippase activity. Cell Physiol Biochem (2011) 0.76
Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids. MBio (2015) 0.85
Atorvastatin as a promising anticryptococcal agent. Int J Antimicrob Agents (2017) 0.76